Curaleaf Holdings, Inc. (OTCMKTS:CURLF – Get Free Report) reached a new 52-week low during mid-day trading on Thursday . The stock traded as low as $0.81 and last traded at $0.85, with a volume of 466595 shares. The stock had previously closed at $0.89.
Curaleaf Stock Performance
The company has a debt-to-equity ratio of 0.85, a current ratio of 1.11 and a quick ratio of 0.51. The company’s fifty day moving average price is $1.19 and its 200 day moving average price is $1.86. The company has a market cap of $509.63 million, a PE ratio of -2.66 and a beta of 0.95.
Curaleaf (OTCMKTS:CURLF – Get Free Report) last posted its earnings results on Monday, March 3rd. The company reported $0.02 EPS for the quarter, topping the consensus estimate of ($0.07) by $0.09. Curaleaf had a negative net margin of 14.82% and a negative return on equity of 13.67%. The firm had revenue of $331.05 million for the quarter, compared to analysts’ expectations of $331.87 million. On average, equities research analysts predict that Curaleaf Holdings, Inc. will post -0.25 earnings per share for the current year.
About Curaleaf
Curaleaf Holdings, Inc operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles.
Further Reading
- Five stocks we like better than Curaleaf
- What is the Euro STOXX 50 Index?
- Conagra Stock Could Thrive as Tariffs Hit Other Sectors
- Stock Average Calculator
- Grocery Costs and Tariffs Now Top of Mind in Everyday Conversations, New Survey Finds
- Bank Stocks – Best Bank Stocks to Invest In
- Spotify Stock Eyes Double-Digit UpsideāIs Now the Time to Buy?
Receive News & Ratings for Curaleaf Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Curaleaf and related companies with MarketBeat.com's FREE daily email newsletter.